CADENCE PHARMACEUTICALS INC | 2013 | FY | 3


The table below summarizes the issuances of such warrants currently outstanding, including the Black-Scholes valuation model assumptions used to determine the fair value of the warrants:

 

     Date of Issuance  
     December
2012
    December
2011
    June
2010
    November
2007
 

Aggregate shares pursuant to warrants issued

     154,638        158,311        254,793        50,331   

Per share exercise price of warrants issued

   $ 3.88      $ 3.79      $ 7.0645      $ 12.67   

Fair value of warrants issued

   $ 416,000      $ 390,000      $ 1,237,000      $ 474,000   

Expiration date of warrants

     December 9, 2019        December 22, 2018        June 18, 2017        November 30, 2014   

Black-Scholes valuation inputs:

        

Expected volatility

     70.17 %      72.40 %      76.50 %      70.00 % 

Risk-free interest rate

     1.02 %      1.40 %      2.70 %      3.64 % 

Dividend yield

     0.00 %      0.00 %      0.00 %      0.00 % 

Expected term

     7 years        7 years        7 years        7 years   

us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock